[Hemosorption in systemic vasculitis].
The present work summarises the experience gained with the use of extracorporeal hemoperfusion in 45 patients suffering from rheumatic diseases. During hemoperfusion, there was a decrease in the initially activated LDH, CPK, AST, ALT and AP. The reduction of the content of phospholipids and cholesterol in plasma and red blood cells is assessed as an adverse effect of hemoperfusion, since the content of phospholipids and cholesterol was under normal before hemoperfusion. The changes indicated point to the necessity of administering antioxidants and exogenous phospholipids.
N P
NP
Shilkina
Iu A
IuA
Ganin
V I
VI
Alekseev
A G
AG
Pukhov
D002784:Cholesterol / Q000097:blood; D006464:Hemoperfusion; D006801:Humans; D010743:Phospholipids / Q000097:blood; D014657:Vasculitis / Q000097:blood / Q000628:therapy*
D010743:Phospholipids; D002784:Cholesterol
Gemosorbtsiia pri sistemnykh vaskulitakh.